Zhang ZH, Jiang C, Li JX. Reconsideration of the clinical management of hepatic hemangioma. World J Gastrointest Surg 2024; 16(11): 3623-3628 [DOI: 10.4240/wjgs.v16.i11.3623]
Corresponding Author of This Article
Jia-Xin Li, MD, Assistant Professor, Chief Doctor, Division of Liver Surgery, Department of General Surgery and Laboratory of Liver Surgery, and State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Chengdu 610041, Sichuan Province, China. lijiaxin@scu.edu.cn
Research Domain of This Article
Surgery
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Gastrointest Surg. Nov 27, 2024; 16(11): 3623-3628 Published online Nov 27, 2024. doi: 10.4240/wjgs.v16.i11.3623
Reconsideration of the clinical management of hepatic hemangioma
Zhi-Hong Zhang, Chuang Jiang, Jia-Xin Li
Zhi-Hong Zhang, Chuang Jiang, Jia-Xin Li, Division of Liver Surgery, Department of General Surgery and Laboratory of Liver Surgery, and State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, Sichuan Province, China
Author contributions: Zhang ZH, Jiang C, and Li JX contributed to this paper; Zhang ZH designed the overall concept and outline of the manuscript; Jiang C and Li JX contributed to the discussion and design of the manuscript; Zhang ZH and Li JX contributed to the writing and editing of the manuscript, and review of the literature.
Supported bythe Project of Guizhou Provincial Department of Science and Technology, No. LC [2024] 109.
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Jia-Xin Li, MD, Assistant Professor, Chief Doctor, Division of Liver Surgery, Department of General Surgery and Laboratory of Liver Surgery, and State Key Laboratory of Biotherapy and Collaborative Innovation Center of Biotherapy, West China Hospital, Sichuan University, No. 37 Guo Xue Alley, Chengdu 610041, Sichuan Province, China. lijiaxin@scu.edu.cn
Received: July 21, 2024 Revised: September 16, 2024 Accepted: September 24, 2024 Published online: November 27, 2024 Processing time: 101 Days and 3.5 Hours
Abstract
In this letter, we comment on the article by Zhou et al that was published in the recent issue of the World Journal of Gastrointestinal Surgery. This article proposes a new clinical grading system based on a multidisciplinary team, which prompts us to rethink the clinical management of hepatic hemangioma. Hepatic hemangioma is the most common benign solid liver tumor. In general, follow-up and observation for the vast majority of hepatic hemangioma is reasonable. For those patients with symptoms and severe complications, surgical intervention is necessary. Specific surgical indications, however, are still not clear. An effective grading system is helpful in further guiding the clinical management of hepatic hemangioma. In this article, we review the recent literature, summarize the surgical indications and treatment of hepatic hemangioma, and evaluate the potential of this new clinical grading system.
Core Tip: Hepatic hemangioma is the most common benign liver tumor, and the surgical indications and treatment methods have been controversial. With the widespread use of minimally invasive treatments such as minimally invasive hepatectomy, transarterial chemoembolization, and ablation, the treatment for hepatic hemangioma is increasing, potentially leading to overtreatment. A reasonable preoperative grading system helps screen operations to benefit patients and to reduce overtreatment.
